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Background: With the advent of high-resolution ultrasound (US), dilatation of the lactif-
erous ducts can be easily demonstrated at routine breast US examination. The purpose of
this study was to prospectively evaluate the clinical significance of ductal dilatation
detected on breast US study.
Patients and Methods: During a period of 12 months, we examined 16,336 nonlactat-
ing women referred for breast US; about 2.5% of them had a known history of nipple dis-
charge. Routine whole breast US examinations were performed by using high-resolution
US scanners. More attention was paid to detect and document the dilated ducts in the
breasts. Among the 16,336 nonlactating women, 478 (2.9%) had duct dilatation (defined
as duct diameter > 2.0 mm). Patients with dilated ducts were either followed-up for at least
2 years or were aspirated or biopsied according to their US findings.
Results: Of the 478 women with duct dilatation, 387 (81.0%) had no significant internal
echoes in the dilated ducts, 48 (10.0%) had low-level internal echoes inside the ducts,
and 39 (8.2%) had medium-level to relatively high-level internal echoes. Solid nodules in
the ducts were demonstrated in 26 (5.4%) women, and calcified material in five (1.0%).
For patients with intraductal echoes, US-guided aspiration or biopsy was performed to
determine the duct contents; 18 of 26 intraductal nodules were shown to be intraductal
papilloma cytologically and/or histopathologically, two were shown to be intraductal car-
cinoma in situ, and five were epithelial hyperplasia or atypical ductal hyperplasia. The
majority of the other 61 women with internal echoes were found to have inspissated
secretions (50/61, 82.0%), while the remaining 11 showed no cellular component inside,
but the findings were inconclusive.
Conclusion: Multiple dilated ducts depicted on US are rarely associated with intraductal
tumors (p < 0.001). If US can demonstrate solid nodules in the dilated duct, the possibility
of intraductal tumor, especially papilloma, should be considered first. Routine and cautious
evaluation of the dilated duct may depict intraductal tumor even in women without nip-
ple discharge, and may facilitate surgical intervention without unnecessary delay.
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Introduction
Galactography (also called ductography) has shown
its capability to depict small intraductal masses partly
or completely obstructing a contrast-opacified duct,
lesions not identified by either clinical examination
or mammography [1–4]. This technique has been
suggested to investigate the cause of nipple dis-
charge which occurs at least intermittently in up to
10% of women who seek medical help for breast
problems [5,6]. The primary value of galactography
is not to determine whether surgery is indicated or
not, but to locate the precise site of the intraductal
lesions, and to aid the choice of appropriate sur-
gery [7]. However, demonstration of pathological
duct or intraductal tumor in the affected ductal
system might be technically unsuccessful. Recent
advances in high-resolution ultrasonography (US)
enable the clear demonstration of retroareolar ducts
and frequently depict small solid nodules within
the dilated ducts. It is therefore reasonable to obtain
US images of small intraductal tumors without the
need for iodinated contrast or X-ray mammogra-
phy. Lactiferous ducts are often observed in nor-
mal breasts by high-resolution US [8]. Most ducts
visualized on US examination are less than 2 mm
in diameter; a caliber of greater than 2 mm can be
considered unusual or dilated. Lactiferous duct
dilatation is not an uncommon finding on breast
US using state-of-the-art US scanners. The purpose
of this study was to prospectively evaluate the clini-
cal significance of dilated ducts detected on breast
US study.
Patients and Methods
During a period of 12 months, we examined 16,336
nonlactating women referred for breast US study.
This prospective study was conducted to demon-
strate any ductal dilatation in the breast during
routine US examination and to document the mor-
phology of the dilated ducts. Of the 16,336 women
examined, 407 (2.5%) had symptoms or signs of
nipple discharge.
At our institution, routine whole breast US exami-
nations are performed by using US scanners with
high-resolution broadband probes, including two
HDI 5000 scanners (Philips-ATL, Bothell, WA, USA)
and one Logiq 9 scanner (GE Health Care Systems,
Milwaukee, WI, USA), equipped with L12-5 and
M12L linear array transducers. The women’s breasts
were first scanned by two experienced technolo-
gists and then confirmed by two experienced radio-
logists with more than 10 years’ experience in breast
imaging and interventional procedures. A radial
scanning protocol was applied in both breasts, and
the axillas were routinely checked. For every abnor-
mality detected, an orthogonal scan plane on the
region of interest was obtained. All suspicious lesions
or abnormalities were labeled (as clock position and
distance from the nipple). For abnormalities located
in the subareolar region, oblique scans were usually
done to achieve better visualization and better sono-
morphologic evaluation.
The sonographic appearances of the breast
lesions were described according to the BI-RADS US
Lexicon [9] with respect to shape, margin, echotex-
ture, sound transmission characteristics, and archi-
tectural pattern [10–12]. A dilated duct was defined
as one with a diameter greater than 2.0mm. Dilated
ducts were documented with their diameter, num-
ber, internal echoes, and adjacent anatomy or possi-
ble abnormalities. The strength of the internal echoes
was classified as very weak, low-level, medium-level,
relatively high-level, and high-level, with respect to
the echogenicity of the subcutaneous fat and breast
parenchyma. Echogenicity that was merely seen, 
a little more than “anechoic”, was classified as very
weak; echogenicity similar to or equivalent to that
of the subcutaneous fat was classified as low-level;
echogenicity similar to or equivalent to that of breast
parenchyma was classified as relatively high-level;
echogenicity higher than that of breast parenchyma
was defined as high-level; and echogenicity between
that of fat and breast parenchyma was defined as
medium-level.
The US transducer was oriented radial to the
nipple to optimize visualization of the duct and pos-
sible intraluminal structures during the procedure.
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Graded compression (dynamic study) was applied to
all dilated ducts. Fine needle aspiration cytology or
core needle biopsy was performed if there were sig-
nificant formed focal internal echoes in the dilated
ducts, especially if there were demonstrable nod-
ules inside. Women with dilated ducts and without
demonstrable intraluminal lesions were scheduled
for follow-up US studies at 1-year intervals for at
least 2 years.
Results
Of the 16,336 nonlactating women who received
breast US examinations, 478 (prevalence of 2.9%)
were found to have dilated ducts on their sono-
grams. Their mean age was 44 years (range, 21–82
years). Of these 478 women, 258 (54.0%) were
asymptomatic at presentation to the outpatient
clinic, and about one-third (167/478, 34.9%) had
symptoms of recent nipple discharge; 240 women
had a remote history of nipple discharge.
Of the 407 women with a history of symptoms
or signs of nipple discharge, 41% were found to
have ductal dilatation. Less than 20% were referred
for US examinations because of palpable breast nod-
ules with or without nipple discharge (Table 1).
About four-fifths of patients with ductal dilatation
were noted to have multiple dilated ducts, most
commonly bilateral (Table 2). The diameters of the
ducts investigated ranged from 2.0 mm to 15 mm,
but most were between 2.0 mm and 4.0 mm. The
majority of them were anechoic or associated with
very weak internal echoes (90.8%) (Figs. 1 and 2). In
about 8.5%, there were formed echogenic struc-
ture(s) or nodule(s) in the lumen, and there were
Ductal Dilatation on Breast Ultrasonogram
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Table 1. l l f hC inica  mani estations in 478 patients wit
ductal dilatation
n (%)
Asymptomatic at presentation 258 (54.0)
Suspicious or palpable nodules 53 (11.1)
Suspicious or palpable nodules 33 (6.9)
with nipple discharge
Nipple discharge 134 (28.0)
Total 478 (100)
Table 2. fNumber o  dilated ducts
n (%)
Single duct* 110 (23.0)
Multiple ducts† 368 (77.0)
Unilateral 41 (8.6)
Bilateral 327 (68.4)
Total 478 (100)
*Fifteen papillomas and two in situ carcinomas were associated with single
duct dilatation (tumor: 17/110, 15.5%); †two papillomas were associ date
dwith unilateral multiple duct dilatation, and one papilloma was associate
with bilateral multiple duct dilatation (tumor: 3/368, 0.8%).
iF g. 1. yA dilated duct with no internal echoes or diffuse ver
weak internal echoes (arrows).
iF g. 2. A dilated duct with diffuse low-level echoes (arrows).
tiny strongly echogenic spots in the lumen represent-
ing calcified material, crystals or microcalcifica-
tions in 1% (Fig. 3) (Table 3). When the echogenic
nodule in a dilated duct was located in the subareo-
lar region, the focal lesion was most likely due to
intraductal papilloma (52.9%), and occasionally due
to intraductal carcinoma (5.9%). Invasive ductal car-
cinoma might be associated with adjacent ductal
invasion and, in turn, cause ductal dilatation (18
patients); however, because the major US findings
in these instances were chiefly related to an intra-
parenchymal tumor and the dilated ducts were not
so prominent in the central portion, they were not
included in the analysis of the histologic results.
Intraductal nodules could be caused by concrete
secretion (Fig. 4).
In 52 patients, core needle biopsies or surgical
interventions were performed. Eighteen patients
with obvious parenchymal tumors on US examina-
tions were excluded. Histologic or histopathologic
results in the remaining 34 patients showed duct
ectasia, sclerosing adenosis, epithelial hyperplasia,
atypical ductal hyperplasia, and intraductal papil-
lomas or carcinomas (Table 4). The most common
pathologies were papillomas (52.9%), which were
most commonly located in the subareolar region
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iF g. 3. yA prominently dilated duct with medium- to relativel
high-level internal echoes and some tiny calcified spots (arrow-
head).
Table 3. h f d l d dSonograp ic appearances o  i ate  ucts
n (%)
No significant internal echoes 386 (80.8)
Low-level internal echoes 48 (10.0)
Diffuse 33 (6.9)
Focal 15 (3.1)
Medium- to relatively high-level 39 (8.2)
internal echoes
Diffuse 13 (2.7)
Focal 26 (5.4)
Intraductal calcifications 5 (1.0)
Total 478 (100)
iF g. 4. A dilated duct with focal (formed) medium- to rela-
tively high-level internal echoes (arrows), representing concrete
secretion.
Table 4. l h h l lHisto ogic or istopat o ogic resu ts in
34 patients
n (%)
Nonproliferative epithelial changes 9 (26.5)
Duct ectasia 6 (17.6)
Sclerosing adenosis 3 (8.8)
Cysts and/or fibrosis (associated findings)* 4 (11.7)
Apocrine metaplasia (associated findings)* 3 (8.8)
Proliferative changes (ductal origin)† 25 (73.5)
Epithelial hyperplasia 4 (11.8)
Atypical ductal hyperplasia 1 (2.9)
Intraductal papilloma 18 (52.9)
Intraductal carcinoma 2 (5.9)
Total 34 (100)
*Associated histopathologic findings combined in other pathologies;
†pathologies with obvious parenchymal tumors on ultrasonography (e.g.
invasive ductal carcinoma) were excluded.
(15/18). The intraductal tumors usually presented
as intraluminal nodules of medium-level echogenic-
ity, ranging in size from 4 mm to 7.5 mm, with the
anteroposterior (AP) dimension greater than that of
the adjacent duct lumen, and causing interruption
of the anechoic or very weak internal echoes in the
ductal lumen (Fig. 5), or presented as ovoid nodules
occupying the peripheral blind end of the duct with
the central portion (toward the nipple) of the duct
dilated (Fig. 6). In only one patient was the intralu-
minal nodule very tiny (<3 mm); it could barely be
visualized in the lumen on US (attaching on one side
of the duct). Tumors were most commonly noted
in a single dilated duct; 15 papillomas and two 
in situ carcinomas were associated with single duct
dilatation. The prevalence of papilloma in single
duct dilatation was 13.6% and that of in situ carci-
noma was 1.8%. Two papillomas were associated
with unilateral multiple duct dilatation (4.9%) and
one papilloma was associated with bilateral multiple
duct dilatation (0.3%). Only three intraductal papil-
lomas were noted in patients with multiple dilated
ducts (0.8%). The multiplicity of the nature of ductal
dilatation carried significantly lower risk for intra-
ductal tumor (p < 0.001) (Table 2). The inspissated
secretion in the dilated duct could be quite echo-
genic, and the lumen of the duct could be greater
than 10 mm, and occasionally they were focally
dilated (Fig. 3). In women with multiple dilated
ducts without demonstrable intraductal tumor or
inspissated secretions, regular follow-up with US at
1-year intervals for at least 2 years showed no signifi-
cant changes in the caliber of the ducts. No tumors
were noted in the dilated ducts at the follow-up US
studies (Fig. 7).
Discussion
The breast is made up of milk-producing lobular
units that are connected to the nipple by a system
of collecting ducts. There are about 15–20 collect-
ing ducts arranged in a radial pattern. The diameter
of normal ducts varies according to their location;
ducts are most prominent in the lactiferous sinus
(usually 2–3 mm), followed by the collecting duct
(<1–2 mm), with a progressive dichotomic division
into 1st, 2nd and 3rd orders with their diameters
being progressively reduced [8,13]. Normal ducts
on high-resolution US, when not dilated and sur-
rounded by fibroglandular tissue, show a thin hyper-
echoic linear structure that represents the closely
adjacent anterior and posterior ductal walls. If the
lumen of the duct is relatively wide, the anechoic
lumen separates the ductal walls and the lumen is
measurable on US.
Ductal dilatation in association with nipple dis-
charge is a condition that is commonly seen in
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iF g. 5. cA subareolar dilated duct filled with a focal hypoechoi
nodule of medium-level echogenicity (arrow), representing a
papilloma.
iF g. 6. Dilated ducts, one of which is filled with formed low-
level internal echoes, representing a tumor arising from a
lbranch (arrows). The lesion turned out to be an intraducta
carcinoma.
patients aged 30 onwards. Also known as secretory
disease, duct ectasia is usually bilateral and charac-
terized by obstruction ducts, frequently due to
epithelial hyperplasia. The associated proximal
dilatation may be cystic. The dilated and tortuous
bead-appearing ducts are often visible on mammo-
grams, particularly in the subareolar region. The bila-
teral nature of the condition aids in its diagnosis
[14]. Ductal ectasia or ductal dilatation is charac-
terized by progressive dilatation of the mammary
duct system, usually commencing beneath the nip-
ple. The condition has been considered to be asso-
ciated with an inflammatory process of the breast,
and has therefore been referred to as periductal
mastitis, plasma cell mastitis, comedo mastitis, or
obliterative mastitis [5]. In the earliest stages, the
dilated ducts are surrounded by chronic inflam-
matory cells including a high proportion of plasma
cells. In the later stage, the duct wall is fibrotic and
the epithelium may be entirely missing. Tenacious
green material may be present within the lumen of
the ducts. Calcification of the duct, either inside the
lumen or on the walls, may occur and sometimes
mimic ductal carcinoma in situ on mammogram.
Mammography might demonstrate the calcifica-
tions that develop in duct ectasia, which are located
within inspissated secretions or within the duct walls.
They can be either tubular or circular with a lucent
center. Most of the calcifications are greater than
1 mm in diameter, and they are frequently arranged
in a linear fashion; occasionally, intraductal calcifica-
tions can be recognized by the branching format.
Calcification of inspissated secretions in or imme-
diately adjacent to benign dilated ducts produces
a typical mammographic appearance: linear, oval or
round calcification, usually bilateral and often asym-
metric in distribution. The calcifications are substan-
tially larger in both length and caliber than those
associated with malignancy. The typical mammo-
graphic pattern of calcifications related to inspis-
sated secretion in dilated ducts help distinguish this
benign condition from other malignant pathologies
with microcalcification [14]. However, mammo-
graphic visualization of dilated ducts may not be
successful in women with dense breasts. In the pres-
ent 478 cases with ductal dilatation, 93 (19.5%) had
had mammographic study within 1 month avail-
able for comparison, and only 27 (29.0%, 27/93)
had mammographically demonstrable ductal dilata-
tion in the subareolar region. Typical calcifications
suggestive of ductal ectasia were noted in six (6.5%)
patients. Nipple retraction can be noted occasion-
ally in some patients with ductal ectasia. Nipple
retraction is commonly secondary to congenital
anomaly secretory disease and carcinoma, and care
must be taken to exclude evidence of malignancy
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iF g. 7. d(A) A single dilated duct measuring 3.7 mm in diameter with diffuse low-level internal echoes (arrows). (B) At the 1- an
2-year follow-up ultrasound studies, the dilated duct shows a decreased diameter of 2.8 mm and also decreased strength of intern la
echoes (arrows).
deep within the nipple, particularly if the sign is
unilateral.
US examination has a demonstrable role in detec-
ting dilated ducts as well as intraductal content.
Secretions within dilated ducts may be anechoic,
nearly anechoic, minimally echogenic, isoechoic with
the subcutaneous fat, or even solid appearing. The
echogenicity of the secretions depends on the fatty
content and the duration of stasis. Medium-level,
relatively high- or high-level internal echoes may
appear solid in the ductal lumen. Solid appearing
secretions typically represent inspissated, highly fatty
secretions which have a cheesy appearance at needle
aspiration. Fluid–debris (or oil) level within a dila-
ted duct may simulate an intraductal papilloma.
Graded compression of the duct with the trans-
ducer may cause the echogenic secretions to float
or swirl within the intraductal fluid, distinguishing
the debris from a true intraductal tumor. Changing
the patient’s position to observe the debris change
to the new dependent position within the duct may
help distinguish these two conditions. Fine needle
aspiration or core needle biopsy can be a method of
choice to solve the problem if there is difficulty in
differentiating inspissated concrete secretion from
intraductal tumor. The procedure can be carried out
on an outpatient basis [15].
The ultrasound characteristics of a tumor within
or adjacent to a dilated duct may be more inform-
ative than mammography [16]. US is definitely pre-
ferred because this investigation does not carry
ionizing radiation hazard, and it adds to the diag-
nostic accuracy in younger women or in women
with dense breasts [16]. On the basis of the present
study, routine breast US can depict ductal dilata-
tion at a prevalence of 2.9% of women referred for
breast US examination. The multiplicity of the
nature of duct ectasia carries very low risk for intra-
ductal tumor (0.8%), while single duct dilatation is
frequently associated with papilloma (13.6%) or
carcinoma (1.8%).
Intraductal papilloma frequently presents as
a solitary papillary lesion growing in one of the main
ducts close to the nipple. It usually presents with a
serous or blood-stained discharge from a single duct
underneath the nipple. Galactography can help to
demonstrate and diagnose intraductal abnormali-
ties and their extent in the ductal system. It is valu-
able in planning surgical intervention. Many studies
have stressed that the diagnosis can be best made
by galactography prior to excision of the affected
duct and segment of breast tissue [17–19]. However,
the procedure may have to be repeated because of
technical failure, mainly due to leakage of contrast
medium out of the duct system into the surround-
ing tissue. The technique is also relatively invasive,
and mastitis is the most common complication,
although it is unusually seen [20–23]. With the
recent advent of high-resolution US, more and
more intraductal papillomas are being diagnosed
during routine breast US examinations. The results
of this present study suggest that single duct
dilatation carries a 13.6% possibility of intraductal
papilloma.
In some patients, the dilated ducts were asso-
ciated with cysts or fibrocystic change. The histo-
pathologic examination showed ductal epithelial
hyperplasia and atypical ductal hyperplasia in some
of the representative specimens. These pathologies
are of clinical significance because they are at risk
of developing into breast carcinoma [24]. The real
prevalence of epithelial hyperplasia and atypical
ductal hyperplasia in patients with dilated ducts is
unknown. In this study, only 10% of patients under-
went biopsy and/or surgical intervention, however,
for ductal dilatation without a pattern of intraluminal
solid nodule (usually suggestive of papilloma), the
prevalence of epithelial hyperplasia and atypical
ductal hyperplasia can be as high as 20%. It is there-
fore worthwhile to recommend regular US follow-
up for women with ductal dilatation demonstrated
on US, especially in patients with single duct
dilatation.
In conclusion, with modern high-resolution US,
dilated lactiferous ducts can be detected and the
intraluminal echoes can be demonstrated well.
Special care should be taken to evaluate intraductal
nodules. Special expertise is required to interpret
the images, and operators should accumulate more
experience with the US examination technique.
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